Review
BibTex RIS Cite

Osteoporoz Tanısı ve İzlem Parametreleri

Year 2019, Volume: 11 Issue: 3, 119 - 121, 03.05.2019

Abstract

Osteoporoz tanısı için fizik muayene ,kemik yoğunluğu ölçümü, vertebranın radyolojik
olarak görüntülenmesi önemldir. Ayrıca kırık riskini değerlendirmek için çeşitli parametreler
mevcuttur. Osteoporoz tanısının erken dönemde konulması ile kemik kırıklarının
önüne geçilebilir.

References

  • 1- Cosman F, Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014;25:2359-2381.
  • 2- Faulkner KG: Update on bone density measurement. Rheum Dis Clin N Am 2001; 27(1)81.
  • 3- Kanis JA, Oden A, Johnell O, Johansson H, De Laet et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033-1046.
  • 4. Gökçe Kutsal Y: Osteoporoz tanısında görüntüleme yöntemleri ve histomorfometri. In: Gökçe-Kutsal Y(Ed): Osteoporoz.Güneş Kitabevi,Ankara, 2005, pp: 103–124.
  • 5- Mazess RB, Collick B, Trempe J et al. Performance evaluation of a dual energy x-ray bone densitometer. Calcif Tissue Int 1989; 44: 228-232.
  • 6- International Society for Clinical Densitometry. 2013 ISCD Official Positions - Adult. www.iscd.org/ official-positions/2013-iscdofficial- positions-adult/ (Accessed on November 14, 2013.
  • 7- WHO Technical Report Series 843:Assessment of fracture risk and its application to screening for postmenapausal osteoporosis. Geneva, 1994, World Health Organisation.
  • 8- Kanis JA, Melton LJ, et al. : The diagnosis of osteoporosis. J Bone Miner Res, 1994, 9: 1137–1141
  • 9- Gluer CC: The use of bone densitometry in clinical practice. Clin Endocrinol Metab 2000; 14(2):195–211.
  • 10- Lenchik L, Rogers LF, Delmas PD, Genant HK. Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. Am J Roentgenol 2004; 183(4):949–958
  • 11-FRAX WHO Fracture Risc Assessment Tool. http://www.shef.ac.uk/ FRAX/tool.jsp?location Value=] Erişim Tarihi: 10.01.2010.
  • 12- 20.Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97.
  • 13- Hannon RA, Eastell R. Biochemical markers of bone turnover and fracture prediction. J Br Menopause Sec 2003; 9: 10-5.
  • 14 -Nelson HD, Helfand M. Screening for postmenopausal osteoporosis. Agency for Healthcare Research and Quality , 2002.
Year 2019, Volume: 11 Issue: 3, 119 - 121, 03.05.2019

Abstract

References

  • 1- Cosman F, Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 2014;25:2359-2381.
  • 2- Faulkner KG: Update on bone density measurement. Rheum Dis Clin N Am 2001; 27(1)81.
  • 3- Kanis JA, Oden A, Johnell O, Johansson H, De Laet et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033-1046.
  • 4. Gökçe Kutsal Y: Osteoporoz tanısında görüntüleme yöntemleri ve histomorfometri. In: Gökçe-Kutsal Y(Ed): Osteoporoz.Güneş Kitabevi,Ankara, 2005, pp: 103–124.
  • 5- Mazess RB, Collick B, Trempe J et al. Performance evaluation of a dual energy x-ray bone densitometer. Calcif Tissue Int 1989; 44: 228-232.
  • 6- International Society for Clinical Densitometry. 2013 ISCD Official Positions - Adult. www.iscd.org/ official-positions/2013-iscdofficial- positions-adult/ (Accessed on November 14, 2013.
  • 7- WHO Technical Report Series 843:Assessment of fracture risk and its application to screening for postmenapausal osteoporosis. Geneva, 1994, World Health Organisation.
  • 8- Kanis JA, Melton LJ, et al. : The diagnosis of osteoporosis. J Bone Miner Res, 1994, 9: 1137–1141
  • 9- Gluer CC: The use of bone densitometry in clinical practice. Clin Endocrinol Metab 2000; 14(2):195–211.
  • 10- Lenchik L, Rogers LF, Delmas PD, Genant HK. Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. Am J Roentgenol 2004; 183(4):949–958
  • 11-FRAX WHO Fracture Risc Assessment Tool. http://www.shef.ac.uk/ FRAX/tool.jsp?location Value=] Erişim Tarihi: 10.01.2010.
  • 12- 20.Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97.
  • 13- Hannon RA, Eastell R. Biochemical markers of bone turnover and fracture prediction. J Br Menopause Sec 2003; 9: 10-5.
  • 14 -Nelson HD, Helfand M. Screening for postmenopausal osteoporosis. Agency for Healthcare Research and Quality , 2002.
There are 14 citations in total.

Details

Primary Language Turkish
Subjects ​Internal Diseases
Journal Section makaleler
Authors

Mustafa Aziz Yıldırım This is me

Publication Date May 3, 2019
Published in Issue Year 2019 Volume: 11 Issue: 3

Cite

APA Yıldırım, M. A. (2019). Osteoporoz Tanısı ve İzlem Parametreleri. Klinik Tıp Aile Hekimliği, 11(3), 119-121.
AMA Yıldırım MA. Osteoporoz Tanısı ve İzlem Parametreleri. Aile Hekimliği. May 2019;11(3):119-121.
Chicago Yıldırım, Mustafa Aziz. “Osteoporoz Tanısı Ve İzlem Parametreleri”. Klinik Tıp Aile Hekimliği 11, no. 3 (May 2019): 119-21.
EndNote Yıldırım MA (May 1, 2019) Osteoporoz Tanısı ve İzlem Parametreleri. Klinik Tıp Aile Hekimliği 11 3 119–121.
IEEE M. A. Yıldırım, “Osteoporoz Tanısı ve İzlem Parametreleri”, Aile Hekimliği, vol. 11, no. 3, pp. 119–121, 2019.
ISNAD Yıldırım, Mustafa Aziz. “Osteoporoz Tanısı Ve İzlem Parametreleri”. Klinik Tıp Aile Hekimliği 11/3 (May 2019), 119-121.
JAMA Yıldırım MA. Osteoporoz Tanısı ve İzlem Parametreleri. Aile Hekimliği. 2019;11:119–121.
MLA Yıldırım, Mustafa Aziz. “Osteoporoz Tanısı Ve İzlem Parametreleri”. Klinik Tıp Aile Hekimliği, vol. 11, no. 3, 2019, pp. 119-21.
Vancouver Yıldırım MA. Osteoporoz Tanısı ve İzlem Parametreleri. Aile Hekimliği. 2019;11(3):119-21.